Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameBreast and Cervical Cancer Early Detection and Control Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2019Committee Number1952
Original Establishment Date10/3/1994Committee StatusChartered
Actual Termination Date Committee URLhttps://www.cdc.gov/maso/facm/facmbccedcac.html
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*Unlimited
Current Charter Date9/12/2018Designated Fed Officer Position Title*DFO, BCCEDCAC
Date Of Renewal Charter9/12/2020Designated Federal Officer PrefixMs.
Projected Termination Date Designated Federal Officer First Name*Jameka
Exempt From Renewal*NoDesignated Federal Officer Middle NameR
Specific Termination AuthorityDesignated Federal Officer Last Name*Blackmon
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixMBA, CMP
Specific Establishment Authority*42 U.S.C. 217aDesignated Federal Officer Phone*(770) 488-4740
Effective Date Of Authority*12/14/1993Designated Federal Officer Fax*770-488-3230
Committee Type*ContinuingDesignated Federal Officer Email*gzr4@cdc.gov
Presidential*No
Committee Function*Non Scientific Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The committee makes recommendations regarding national program goals and objectives, implementation strategies, program priorities including surveillance, epidemiologic investigations, education and training, information dissemination, professional interactions and collaborations, and policy.
How is membership balanced?*Current members are knowledgeable in the field of medicine including public health, epidemiology, endocrinology, family medicine, health education, oncology, and obstetrics and gynecology. Membership includes representatives of the general public, American Cancer Society, and ex-officio's representing the Food and Drug Administration, the Indian Health Service, National Institutes of Health and additional officials necessary to hold an effective meeting.
How frequent & relevant are cmte mtgs?*The committee usually meets annually. This meeting addressed topics including How to approach health systems change and what CDC is currently doing to address these issues; enhancing population-based screening through monitoring; performance management; approaches to decreasing disparities; and breast cancer mortality disparities.
Why advice can't be obtained elsewhere?*The Breast and Cervical Cancer Early Detection and Control Advisory Committee provides advice and guidance to the Secretary, HHS, and the Director, CDC, regarding the early detection and control of breast and cervical cancer. The committee makes recommendations regarding national program goals and objectives; implementation strategies; program priorities, including surveillance; epidemiologic investigations; education and training; information dissemination; professional interactions and collaborations; and policy.
Why close or partially close meetings?N/A
Recommendation RemarksNo reports required for this committee. Member Carolyn Aoyama left the committee on 8/31/2017, which should have been reported on the 2017 ACR, but was not.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchNoAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction Commentn/a
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome Commentn/aNumber Of Grants Recommended0
Cost Savings*NoneDollar Value Of Grants Recommended$0.00
Cost Savings Commentn/aGrants Review Commentn/a
Number Of Recommendations*17Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe committee made two key recommendations to CDC in FY18, however, 13 of the 17 recommendations have been considered by the Program and have been fully implemented as of FY18.Access Agency WebsiteYes
% of Recs Fully Implemented*76.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentCommittee recommendations have been considered by the Program and 13 of the 17 recommendations have been implemented. As of FY 18 the program fully implemented one additional recommendation made in FY15:9) The NBCCEDP must follow national guidelines for cervical cancer screening recommended by the USPSTF and clinical societies. CDC is currently supporting a current project to explore alternative cervical cancer screening modalities for geographically hard to serve women in the Pacific Island Jurisdiction.The remaining recommendations continue to be fully implemented as of FY17:1) Priority populations for the NBCCEDP nationally include low income women (at = 250% of the Federal Poverty Level) and women who are uninsured or underinsured. 2) Patient navigation (PN) and community health workers are now allowed costs in the NBCCEDP. A PN program policy has been developed and a method to measure PN services is under development.3) A requirement of the FOA funding a new 5-year cycle of the NBCCEDP (2017-2022) includes the implementation of evidenced-based interventions (EBIs) proven effective in increasing breast and cervical cancer screening as recommended in the Community Guide. Grantees partner with health systems’ clinics in to implement EBIs and improve practice. 4) A well thought out comprehensive plan to evaluate the NBCCEDP (2017-2022) has been developed. 5) CDC funds the CRCCP (Colorectal Cancer Control Program) which is focused on implementing EBIs to increase colorectal cancer screening in partnership with health systems’ clinics. In particular, grantees partner with FQHCs that serve a high-risk, low income, low-screened population. The NBCCEDP’s efforts to implement EBIs in health system clinics will mirror the successful approach of the CRCCP and build on their lessons learned over the past two years on how to effectively engage health systems partners. Additionally, CDC funded several states to pilot projects to collaborate with Medicaid Programs. Those lessons learned are in review and will be disseminated to NBCCEDP and CRCCP grantees.7) NBCCEDP eligibility criteria has been maintained at = 250% of the FPL.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*24.00%Access PublicationsNo
% of Recs Partially Implemented CommentCommittee recommendations are being considered by the Program as to their feasibility or implementation. 4 of the 17 recommendations have been partially implemented. As of FY18 the following FY18 Recommendations were partly implemented: 1) NBCCEDP staff have engaged with HRSA regarding developing a breast cancer screening UDS measure. This is under discussion at HRSA. 2) CDC staff are exploring the use of shared decision making with assistance of external subject matter experts and are planning to collect surveillance data on its use and outcomes. As of FY17 the following FY15 Recommendations were partly implemented with additional activities taking place in FY18: 6) CDC has not evaluated the capacity of NBCCEDP to improve health equity, however, addressing health disparities is a program priority. Grantees are required to target outreach to low income, un- or underinsured women for screening and they are required to partner with health systems that serve high-risk, low income, low-screened populations to implement systems-level improvements in cancer screening. CDC will began to collect data on the reach of the program through systems-level interventions once OMB approval is obtained. 8) Risk assessment and decision-making guides were more appropriately developed for the general population of women who are age-appropriate for screening versus just for NBCCEDP providers or women.Access OtherNo
Agency Feedback*YesAccess Commentn/a
Agency Feedback CommentFeedback is given at official Advisory Committee Meetings.Narrative Description*The Breast and Cervical Cancer Early Detection and Control Advisory Committee (BCCEDCAC) provides advice and guidance to the Secretary, HHS, and the Director, CDC, regarding the early detection and control of breast and cervical cancer. The committee makes recommendations regarding national program goals and objectives; implementation strategies; program priorities, including surveillance; epidemiologic investigations; education and training; information dissemination; professional interactions and collaborations; and policy.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members* Est Payments to Non-Fed Members Next FY* 
Payments to Federal Members* Est. Payments to Fed Members Next FY* 
Payments to Federal Staff* Estimated Payments to Federal Staff* 
Payments to Consultants* Est. Payments to Consultants Next FY* 
Travel Reimb. For Non-Federal Members* Est Travel Reimb Non-Fed Members nextFY* 
Travel Reimb. For Federal Members* Est Travel Reimb For Fed Members* 
Travel Reimb. For Federal Staff* Est. Travel Reimb to Fed Staff Next FY* 
Travel Reimb. For Consultants* Est Travel Reimb to Consultants Next FY* 
Other Costs Est. Other Costs Next FY* 
Total Costs$0.00Est. Total Next FY*$0.00
Federal Staff Support (FTE)* Est. Fed Staff Support Next FY* 
Hide Section - Custom Links

Custom Links

     Committee Level Reports               
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-034649Breast and Cervical Cancer Early Detection and Control Advisory Committee2018
 COM-001858Breast and Cervical Cancer Early Detection and Control Advisory Committee2017
 COM-002267Breast and Cervical Cancer Early Detection and Control Advisory Committee2016
 COM-004084Breast and Cervical Cancer Early Detection and Control Advisory Committee2015
 COM-004762Breast and Cervical Cancer Early Detection and Control Advisory Committee2014
 COM-005911Breast and Cervical Cancer Early Detection and Control Advisory Committee2013
 COM-006611Breast and Cervical Cancer Early Detection and Control Advisory Committee2012
 COM-008009Breast and Cervical Cancer Early Detection and Control Advisory Committee2011
 COM-008854Breast and Cervical Cancer Early Detection and Control Advisory Committee2010
 COM-010404Breast and Cervical Cancer Early Detection and Control Advisory Committee2009
 COM-010827Breast and Cervical Cancer Early Detection and Control Advisory Committee2008
 COM-012084Breast and Cervical Cancer Early Detection and Control Advisory Committee2007
 COM-012527Breast and Cervical Cancer Early Detection and Control Advisory Committee2006
 COM-014010Breast and Cervical Cancer Early Detection and Control Advisory Committee2005
 COM-014731Breast and Cervical Cancer Early Detection and Control Advisory Committee2004
 COM-015874Breast and Cervical Cancer Early Detection and Control Advisory Committee2003
 COM-016386Breast and Cervical Cancer Early Detection and Control Advisory Committee2002
 COM-017863Breast and Cervical Cancer Early Detection and Control Advisory Committee2001
 COM-018499Breast and Cervical Cancer Early Detection and Control Advisory Committee2000
 COM-019517Breast and Cervical Cancer Early Detection and Control Advisory Committee1999
 COM-020355Breast and Cervical Cancer Early Detection and Control Advisory Committee1998
 COM-021657Breast and Cervical Cancer Early Detection and Control Advisory Committee1997